InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Ellingson Rachel, Directeur de la Stratégie. Insider active across 2 companies, notably Zimmer Biomet Holdings, INC.. Aggregated, 17 reports have been recorded. History available since 1 May 2021. The latest transaction was filed on 20 February 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Ellingson Rachel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
8,170 股Common StockSEC:0001628280-26-012476:0
6,876 股Common StockSEC:0001628280-25-014186:0
1,566 股0Common StockSEC:0001062993-25-003344:0
5,572 股0Common StockSEC:0001062993-25-002910:0
11,264 股Common StockSEC:0001628280-24-010751:0
1,419 股0Common StockSEC:0001062993-24-006022:0
1,762 股0Common StockSEC:0001062993-24-004687:0
495 股Common StockSEC:0001628280-23-036780:0
362 股Common StockSEC:0001628280-23-034206:0
1,046 股0Common StockSEC:0001062993-23-004623:0
10,187 股Common StockSEC:0001437749-23-001264:0
259 股Common StockSEC:0001437749-22-018511:0
341 股Common StockSEC:0001437749-22-016765:0
311 股Common StockSEC:0001437749-22-014307:0
14,730 股Common StockSEC:0001437749-22-011803:0
531 股0Common StockSEC:0001062993-22-011409:0
515 股0Common StockSEC:0001062993-21-004047:0
17 条申报中的 17 条
About Ellingson Rachel
Ellingson Rachel is Director de la Stratégie. She is associated with Biolife Solutions INC, where she is Director, and with Zimmer Biomet Holdings, INC., where she is Chief Administrative Officer. The record shows 17 filings in total, and the recent filings observed run from 2021-05-03 to 2026-02-26. The buy and sell volumes shown for this recent sample are 0 EUR each, and the most frequent transaction nature is Attribution.
